No abstract
J Transl Med. 2026 Feb 3. doi: 10.1186/s12967-026-07779-x. Online ahead of print.
NO ABSTRACT
PMID:41629949 | DOI:10.1186/s12967-026-07779-x
The HKDC1-ASS1-ACSBG2 axis reprograms lipid metabolism to drive therapeutic resistance in hepatocellular carcinoma
Scritto il 03/02/2026
da Xiangyu Ling